Barclays analyst Steve Valiquette raised the firm’s price target on Universal Health to $132 from $115 and keeps an Underweight rating on the shares. The analyst says Barclays healthcare labor tracker shows notable secular improvement in Q4 versus Q3. Universal Health showed improvement in acute care, Valiquette tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on UHS:
- Universal Health price target raised to $168 from $130 at Deutsche Bank
- Universal Health upgraded to Equal Weight on improved rates at Wells Fargo
- Universal Health upgraded to Equal Weight from Underweight at Wells Fargo
- Universal Health upgraded to Neutral at BofA amid multi-year industry tailwinds
- Universal Health upgraded to Neutral from Underperform at BofA
Questions or Comments about the article? Write to editor@tipranks.com